MedicinePOM

Afibercept

Eye injection for macular degeneration and diabetic eye disease.

Clinical information

Common uses

wet age-related macular degeneration
macular oedema after retinal vein occlusion
diabetic macular oedema
diabetic retinopathy

Common side effects

bleeding on the surface of the eye
eye pain
cataract
vitreous floaters or detachment
raised eye pressure

Cautions

not given during eye or nearby infection
report eye pain or vision changes promptly — infection risk
possible risk of blood-clot (thromboembolic) events

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Yesafili (aflibercept-jbvf) injection label, setid 7d69a7b0-9511-c030-3b85-13b23f9d2980 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Afibercept	Parenteral ( Injection for intravitreal)	40mg/ml	—	POM